1-10 of 10
Brandi Hilder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Treated with Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody: Patient-Reported Outcomes from MonumenTAL-1

Cyrille Touzeau, Ajai Chari, Carolina Schinke, Monique C. Minnema, Jesus Berdeja, Albert Oriol, Niels WCJ Van De Donk, Paula Rodriguez Otero, Elham Askari, Maria-Victoria Mateos, Luciano J. Costa, Jo Caers, Leo Rasche, Amrita Y. Krishnan, Deeksha Vishwamitra, Xuewen Ma, Xiang Qin, Katharine S. Gries, Kelly Kato, Michela Campagna, Tara Masterson, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Jenna D. Goldberg, Chris Heuck, Philippe Moreau, Jesús San-Miguel
Journal: Blood
Blood (2022) 140 (Supplement 1): 4447–4449.
https://doi.org/10.1182/blood-2022-162555
Published: 2022
Journal Articles

Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 Results from MonumenTAL-1

Ajai Chari, Cyrille Touzeau, Carolina Schinke, Monique C. Minnema, Jesus Berdeja, Albert Oriol, Niels WCJ Van De Donk, Paula Rodriguez Otero, Elham Askari, Maria-Victoria Mateos, Luciano J. Costa, Jo Caers, Leo Rasche, Amrita Y. Krishnan, Deeksha Vishwamitra, Xuewen Ma, Xiang Qin, Katharine S. Gries, Michela Campagna, Tara Masterson, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Jenna D. Goldberg, Christoph Heuck, Jesús San-Miguel, Philippe Moreau
Journal: Blood
Blood (2022) 140 (Supplement 1): 384–387.
https://doi.org/10.1182/blood-2022-159707
Published: 2022
Journal Articles

A Phase 1 Study Of ARRY-520 With Bortezomib (BTZ) and Dexamethasone (dex) In Relapsed Or Refractory Multiple Myeloma (RRMM)

Ajai Chari, MD, Myo Htut, MD, Jeffrey Zonder, M.D., Joseph W. Fay, MD, Andrzej J Jakubowiak, MD, PhD, Beverly Harrison, Kenneth Lau, BA, Brandi Hilder, Ann Ptaszynski, Selena A Rush, BS, Jonathan L. Kaufman, MD, Steven Michael Burt
Journal: Blood
Blood (2013) 122 (21): 1938.
https://doi.org/10.1182/blood.V122.21.1938.1938
Published: 2013
Journal Articles

Phase 1 Study Of The Novel Kinesin Spindle Protein Inhibitor ARRY-520 + Carfilzomib (Car) In Patients With Relapsed and/Or Refractory Multiple Myeloma (RRMM)

Jatin J. Shah, M.D., Lei Feng, M.S., Sheeba K. Thomas, M.D., Donna M. Weber, M.D., Michael Wang, MD, Brandi Hilder, Raymond Alexanian, M.D., Robert Z. Orlowski, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 1982.
https://doi.org/10.1182/blood.V122.21.1982.1982
Published: 2013
Journal Articles

Prolonged Survival and Improved Response Rates With ARRY-520 In Relapsed/Refractory Multiple Myeloma (RRMM) Patients With Low α-1 Acid Glycoprotein (AAG) Levels: Results From a Phase 2 Study

Sagar Lonial, M.D., Jatin J. Shah, M.D., Jeffrey Zonder, M.D., William I. Bensinger, MD, Adam D. Cohen, MD, Jonathan L. Kaufman, MD, Ajay K. Nooka, MD, MPH, Donna M. Weber, M.D., Brandi Hilder, Selena A Rush, BS, Ann Ptaszynski, Duncan Walker, PhD, Robert Z. Orlowski, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 285.
https://doi.org/10.1182/blood.V122.21.285.285
Published: 2013
Journal Articles

The Novel KSP Inhibitor ARRY-520 Is Active Both with and without Low-Dose Dexamethasone in Patients with Multiple Myeloma Refractory to Bortezomib and Lenalidomide: Results From a Phase 2 Study

Jatin J. Shah, M.D., Jeffrey A. Zonder, MD, Adam Cohen, MD, William Bensinger, MD, Jonathan L. Kaufman, MD, Robert Z. Orlowski, M.D., Ph.D., R. Donald Harvey, PharmD, Muneer H. Abidi, MD, Sheeba K. Thomas, MD, Duncan Walker, PhD, Brandi Hilder, Ann Marie Ptaszynski, MD, Sagar Lonial, MD
Journal: Blood
Blood (2012) 120 (21): 449.
https://doi.org/10.1182/blood.V120.21.449.449
Published: 2012
Journal Articles

Identification of Alpha 1-Acid Glycoprotein (AAG) As a Potential Patient Selection Biomarker for Improved Clinical Activity of the Novel KSP Inhibitor ARRY-520 in Relapsed and Refractory Multiple Myeloma (MM)

Brian Tunquist, Karin Brown, Gary Hingorani, Sagar Lonial, MD, Jonathan L. Kaufman, MD, Jeffrey A. Zonder, MD, Adam D Cohen, MD, William I. Bensinger, MD, Robert Z. Orlowski, M.D., Ph.D., Jatin J. Shah, M.D., Brandi Hilder, Ann Marie Ptaszynski, MD, Kevin Koch, Kevin Litwiler, Duncan Walker
Journal: Blood
Blood (2012) 120 (21): 1868.
https://doi.org/10.1182/blood.V120.21.1868.1868
Published: 2012
Journal Articles

Phase 1 Study of the Novel Kinesin Spindle Protein Inhibitor ARRY-520 + Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma

Jatin J. Shah, M.D., Donna M. Weber, M.D., Sheeba K. Thomas, MD, Raymond Alexanian, M.D., Michael Wang, M.D., Muzaffar H. Qazilbash, MD, Simrit Parmar, M.D., Nina Shah, MD, Qaiser Bashir, MD, Uday R. Popat, M.D., Brandi Hilder, Robert Z. Orlowski, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 4082.
https://doi.org/10.1182/blood.V120.21.4082.4082
Published: 2012
Journal Articles

ARRY-520 Shows Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma in a Phase 1 Dose-Escalation Study

Jatin J Shah, MD, Jeffrey Zonder, MD, Adam Cohen, Robert Z. Orlowski, MD, PhD, Raymond Alexanian, M.D., Sheeba K Thomas, M.D., Donna Weber, MD, Jonathan L. Kaufman, MD, R. Donald Harvey, PharmD, Duncan Walker, PhD, Kevin Litwiler, PhD, Sharon Karan, Brandi Hilder, Ann Marie Ptaszynski, MD, Sagar Lonial, MD
Journal: Blood
Blood (2011) 118 (21): 1860.
https://doi.org/10.1182/blood.V118.21.1860.1860
Published: 2011
Journal Articles

The Novel KSP Inhibitor ARRY-520 Demonstrates Single-Agent Activity in Refractory Myeloma: Results From a Phase 2 Trial in Patients with Relapsed/Refractory Multiple Myeloma (MM)

Sagar Lonial, MD, Adam Cohen, Jeffrey Zonder, MD, William I Benzinger, MD, Jonathan L. Kaufman, MD, Robert Z. Orlowski, MD, PhD, R. Donald Harvey, PharmD, Raymond Alexanian, M.D., Sheeba K Thomas, M.D., Donna Weber, MD, Duncan Walker, PhD, Brandi Hilder, PhD, Ann Ptaszynski, Jatin J Shah, MD
Journal: Blood
Blood (2011) 118 (21): 2935.
https://doi.org/10.1182/blood.V118.21.2935.2935
Published: 2011